These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6744495)

  • 21. Synthesis of new 6H-indolo[2,3-b] [1,8]naphthyridines and their specific inhibition of benzodiazepine receptor.
    Da Settimo A; Primofiore G; Ferrarini PL; Mori C; Martini C; Pennacchi E; Lucacchini A
    Farmaco Sci; 1986 Aug; 41(8):577-85. PubMed ID: 3017748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
    Tsuzuki Y; Tomita K; Sato Y; Kashimoto S; Chiba K
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3189-93. PubMed ID: 15149673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo[3,2-b][1,8]naphthyridine derivatives.
    Hayakawa I; Suzuki N; Suzuki K; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4914-22. PubMed ID: 6534540
    [No Abstract]   [Full Text] [Related]  

  • 24. Acetylene compounds of potential pharmacological value. XL. N-(tert-aminoalkynyl)-substituted 3-isothiazolidinone-1,1-dioxides and tetrahydro-1,2-thiazin-3-one-1,1-dioxides.
    Lindeke B; Dahlbom R; Ringdahl B
    Acta Pharm Suec; 1987; 24(4):161-8. PubMed ID: 3439465
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyridonecarboxylic acids as antibacterial agents. V. Synthesis of 1-vinyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids.
    Mishio S; Hirose T; Minamida A; Matsumoto J; Minami S
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4402-8. PubMed ID: 4092268
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation.
    Madsen-Duggan CB; Debenham JS; Walsh TF; Yan L; Huo P; Wang J; Tong X; Lao J; Fong TM; Xiao JC; Huang CR; Shen CP; Stribling DS; Shearman LP; Strack AM; Goulet MT; Hale JJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3750-4. PubMed ID: 20483606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure-activity relationships in a set of antimuscarinic agents.
    Cappello B; Silipo C; Vittoria A; Pratesi P
    Farmaco Sci; 1984 Dec; 39(12):991-1007. PubMed ID: 6529988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid peptides. Structure-activity relationships in [beta-Ala4]dermorphin tetrapeptides. V.
    Salvadori S; Marastoni M; Tomatis R; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):640-6. PubMed ID: 6641929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and spasmolytic activity of aminoalkyl 2-substituted-2-(1,2-benzisoxazol-3-yl)acetates.
    Naruto S; Ueda S; Yoshida T; Mizuta H; Kawashima K; Kadokawa T
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):2095-100. PubMed ID: 3664813
    [No Abstract]   [Full Text] [Related]  

  • 31. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 32. Opioid peptides. Structure-activity relationships of dermorphin endothiotetrapeptides. VII.
    Salvadori S; Marastoni M; Balboni G; Tomatis R; Sarto G
    Farmaco Sci; 1984 Apr; 39(4):316-21. PubMed ID: 6144571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,8-naphthyridine derivatives: synthesis and pharmacological evaluation of beta-receptor blocking activity.
    Tonetti I; Bertini D; Ferrarini PI; Livi O
    Farmaco Sci; 1976 Mar; 31(3):175-82. PubMed ID: 3435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid peptides. Structure-activity relationships in dermorphin pentapeptides III.
    Salvadori S; Marastoni M; Tomatis R; Sarto G
    Farmaco Sci; 1983 Mar; 28(3):153-60. PubMed ID: 6852228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and local anesthetic activity of (E)- and (Z)-diethylaminoethyliminothers of 1,8-naphtyridine.
    Ferrarini PL; Mori C; Tellini N
    Farmaco; 1990 Mar; 45(3):385-9. PubMed ID: 2383350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative structure-activity relationship study of some 7-substituted theophyllines.
    Türker L; Akgün H; Balkan A
    Arzneimittelforschung; 1998 Jan; 48(1):39-42. PubMed ID: 9522029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible site of action of TAK-637, a tachykinin NK(1) receptor antagonist, on the micturition reflex in guinea pigs.
    Kamo I; Imai S; Okanishi S; Doi T
    Eur J Pharmacol; 2000 Aug; 401(2):235-40. PubMed ID: 10924932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3-Disubstituted 1,8-naphthyridines as potential diuretic agents. 2. 5,7-Dimethyl derivatives.
    Hawes EM; Gorecki DK; Gedir RG
    J Med Chem; 1977 Jun; 20(6):838-41. PubMed ID: 874960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.
    Kim KH; Wissner A; Floyd MB; Fraser HL; Wang YD; Dushin RG; Hu Y; Olland A; Guo B; Arndt K
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5225-8. PubMed ID: 19628388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.